Predictive Oncology Inc. (POAI) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Before we begin, let me quickly remind you that during the course of this presentation, the company will make forward looking statements. We caution you that any statement that is not a statement of historical fact is a forward looking statement. This includes remarks about the company's projections, expectations, plans, beliefs, and future performance, all of which constitute forward-looking statements for the purpose of the safe harbor provision under the Private Securities Litigation Reform Act of 1995. These statements are based on judgment and analysis as of the date of this presentation and are subject to numerous important risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The company cannot guarantee the accuracy, completeness, or reliability of statements made by third parties or advisors in this presentation, nor can it assure that any expectations, forecasts, or outcomes expressed by third parties or advisors will materialize. The risks and uncertainties associated with the forward-looking statements made in this presentation and webcast are described in the company's public periodic filings with the SEC. Except as required by law, the company assumes no obligation to update these forward-looking statements to reflect future events or actual outcomes and does not intend to do so. The slides presented in this presentation can be accessed via the investors page of our website. Good morning, everyone, and welcome to Predictive Oncology's Q3 financial results and business update presentation, which will include an overview of our latest digital asset investment in Aether's ATH token aimed at creating the world's first strategic compute reserve. This investment represents a new bu...